Ravi, M.
Waters, M.
Trinidad, J.
Chung, C. G.
Kaffenberger, B. H. http://orcid.org/0000-0001-8079-0011
Article History
Received: 28 June 2021
Revised: 13 December 2021
Accepted: 21 December 2021
First Online: 6 January 2022
Declarations
:
: Dr. Benjamin Kaffenberger is an investigator for AnaptysBio Inc, Biogen, InflaRx, OnQuality Pharmaceuticals, and Eli Lilly Co and is funded by the Dermatology Foundation.
: Reviewed and approved by The Ohio State University IRB Study ID #2020H0276.
: Not applicable.
: Not applicable.